PARPi activity was also demonstrated for BRCAwt cancers due to mutations in genes critical for DNA repair (e.g., ATM, BARD1, BRIP1, CHEK2, NBN, PALB2, RAD51C, and RAD51D) (34, 35). This evidence concerns the gene CHEK2 and cancer.